{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:34:17Z","timestamp":1740126857037,"version":"3.37.3"},"reference-count":25,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Perinatol"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:p>\n            Objective\u2003In the setting of a growing obese obstetric population, we sought to determine whether differences in body mass index (BMI) and obesity class influenced both serum magnesium levels and the likelihood of achieving therapeutic levels for eclampsia prophylaxis after standard boluses of magnesium sulfate.<\/jats:p><jats:p>\n            Study Design\u2003This is a retrospective cohort study of patients treated with magnesium sulfate in the setting of either preeclampsia with severe features or preterm labor between 2010 and 2016. Subjects were categorized by BMI: Normal (BMI\u2009&lt;\u200930\u2009kg\/m2), Class 1 (BMI 30\u201334.9\u2009kg\/m2), Class 2 (BMI 35\u201339.9\u2009kg\/m2), and Class 3 (BMI \u2265 40\u2009kg\/m2). Study participants' demographics, intrapartum characteristics, and adverse reactions were compared among the groups. Logistic regression models were used to calculate unadjusted and adjusted odds ratios comparing the likelihood of each BMI class reaching therapeutic eclamptic prophylactic levels. Linear regression models were also evaluated to determine the relationship between BMI and post-bolus serum magnesium levels.<\/jats:p><jats:p>\n            Results\u2003Of the 760 people who met the inclusion criteria, 313 (41.1%) had normal BMI, 190 (25.0%) had Class 1 obesity, 135 (17.8%) had Class 2 obesity, and 122 (16.1%) had Class 3 obesity. When adjusted for confounders, those with Class 1 obesity were 54% less likely to achieve serum levels deemed therapeutic for seizure prophylaxis compared with normal BMI counterparts. Meanwhile, those with Class 2 or 3 obesity were 90% less likely. Linear regression models also demonstrated an inverse association between BMI and post-bolus serum magnesium levels.<\/jats:p><jats:p>\n            Conclusion\u2003Increasing BMI has a significant effect on post-bolus serum magnesium levels regardless of standard loading dose used. Immediately after bolus administration, obese gravidas are significantly less likely to reach levels effective for eclamptic seizure prophylaxis. When considering which bolus to administer in an obese gravida, it may be more beneficial to choose a 6\u2009g load.<\/jats:p><jats:p>\n            Key Points\n          <\/jats:p>","DOI":"10.1055\/s-0043-1776902","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T23:47:33Z","timestamp":1699660053000},"page":"677-683","source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Body Mass Index on Post-Bolus Magnesium Levels in the Obstetric Patient"],"prefix":"10.1055","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2473-9702","authenticated-orcid":false,"given":"Madushka Y.","family":"De Zoysa","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of California Irvine, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9437-471X","authenticated-orcid":false,"given":"Melissa","family":"Westermann","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of California Irvine, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7774-7712","authenticated-orcid":false,"given":"Tyler","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of California Irvine, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3256-1465","authenticated-orcid":false,"given":"Judith H.","family":"Chung","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of California Irvine, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"S1237","DOI":"10.1016\/j.ajog.2020.09.037","article-title":"Eclampsia in the 21st century","volume":"226","author":"M Fishel Bartal","year":"2022","journal-title":"Am J Obstet Gynecol"},{"issue":"03","key":"ref2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/AOG.0b013e3181d4ffa5","article-title":"Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection","volume":"115","author":"The American College of Obstetricians and Gynecologists","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"03","key":"ref3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/01.AOG.0000433994.46087.85","article-title":"Committee Opinion No. 573: Magnesium sulfate use in obstetrics","volume":"122","author":"American College of Obstetricians and Gynecologists Committee on Obstetric Practice Society for Maternal-Fetal Medicine","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"06","key":"ref4","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1097\/AOG.0000000000003892","article-title":"Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin Summary, Number 222","volume":"135","author":"J Espinoza","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"03","key":"ref5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"L Duley","year":"2009","journal-title":"Semin Perinatol"},{"issue":"06","key":"ref6","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"L Say","year":"2014","journal-title":"Lancet Glob Health"},{"issue":"9321","key":"ref7","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(02)08778-0","article-title":"Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial","volume":"359","author":"D Altman","year":"2002","journal-title":"Lancet"},{"issue":"03","key":"ref8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9378(16)33027-7","article-title":"Effects of magnesium sulfate treatment on perinatal calcium metabolism. I. Maternal and fetal responses","volume":"134","author":"D P Cruikshank","year":"1979","journal-title":"Am J Obstet Gynecol"},{"issue":"04","key":"ref9","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/00003081-196612000-00010","article-title":"Treatment of severe preeclampsia and eclampsia","volume":"9","author":"F P Zuspan","year":"1966","journal-title":"Clin Obstet Gynecol"},{"issue":"02","key":"ref10","first-page":"199","article-title":"Reassessment of intravenous MgSO4 therapy in preeclampsia-eclampsia","volume":"57","author":"B M Sibai","year":"1981","journal-title":"Obstet Gynecol"},{"key":"ref11","first-page":"315","article-title":"Magnesium sulfate in toxemia of pregnancy. New dosage schedule based on body weight","volume":"19","author":"C E Flowers Jr","year":"1962","journal-title":"Obstet Gynecol"},{"issue":"09","key":"ref12","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa0801187","article-title":"A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy","volume":"359","author":"D J Rouse","year":"2008","journal-title":"N Engl J Med"},{"issue":"20","key":"ref13","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1001\/jama.290.20.2669","article-title":"Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial","volume":"290","author":"C A Crowther","year":"2003","journal-title":"JAMA"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/14767058.2018.1489531","article-title":"A retrospective review of on-admission factors on attainment of therapeutic serum concentrations of magnesium sulfate in women treated for a diagnosis of preeclampsia","volume":"33","author":"J Leetheeragul","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/AOG.0b013e31827d90cc","article-title":"Effect of maternal body mass index on serum magnesium levels given for seizure prophylaxis","volume":"121","author":"C M Tudela","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"06","key":"ref16","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1097\/AOG.0000000000004137","article-title":"Alternate dosing protocol for magnesium sulfate in obese women with preeclampsia: a randomized controlled trial","volume":"136","author":"K F Brookfield","year":"2020","journal-title":"Obstet Gynecol"},{"issue":"03","key":"ref17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1081\/PRG-120024029","article-title":"The use of standard dose of magnesium sulphate in prophylaxis of eclamptic seizures: do body mass index alterations have any effect on success?","volume":"22","author":"V Dayicioglu","year":"2003","journal-title":"Hypertens Pregnancy"},{"issue":"06","key":"ref18","doi-asserted-by":"crossref","first-page":"737.e1","DOI":"10.1016\/j.ajog.2015.12.060","article-title":"Pharmacokinetics and placental transfer of magnesium sulfate in pregnant women","volume":"214","author":"K F Brookfield","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/14767058.2017.1279143","article-title":"Maternal side effects and fetal neuroprotection according to body mass index after magnesium sulfate in a multicenter randomized controlled trial","volume":"31","author":"G Vilchez","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"582.e1","DOI":"10.1016\/j.ajog.2015.06.046","article-title":"Maternal obesity and neuroprotective magnesium sulfate","volume":"213","author":"J McPherson","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"06","key":"ref21","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1097\/AOG.0000000000004395","article-title":"Obesity in Pregnancy: ACOG Practice Bulletin, Number 230","volume":"137","author":"American College of Obstetricians and Gynecologists' Committee on Practice Bulletins\u2013Obstetrics","year":"2021","journal-title":"Obstet Gynecol"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/AOG.0000000000003020","article-title":"ACOG Practice Bulletin No. 203: Chronic Hypertension in Pregnancy","volume":"133","author":"American College of Obstetricians and Gynecologists' Committee on Practice Bulletins\u2014Obstetrics","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"04","key":"ref23","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ajog.2003.09.058","article-title":"Obesity, obstetric complications and cesarean delivery rate\u2013a population-based screening study","volume":"190","author":"J L Weiss","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00000542-196507000-00004","article-title":"Changes in the blood volume during pregnancy and delivery","volume":"26","author":"J A Pritchard","year":"1965","journal-title":"Anesthesiology"},{"issue":"360","key":"ref25","first-page":"1","article-title":"Prevalence of obesity and severe obesity among adults: United States, 2017\u20132018","author":"C M Hales","year":"2020","journal-title":"NCHS Data Brief"}],"container-title":["American Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1776902.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T10:16:35Z","timestamp":1730801795000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0043-1776902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,10]]},"references-count":25,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2024,4,10]]},"published-print":{"date-parts":[[2024,4]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1776902","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0735-1631","1098-8785"],"issn-type":[{"type":"print","value":"0735-1631"},{"type":"electronic","value":"1098-8785"}],"subject":[],"published":{"date-parts":[[2023,11,10]]}}}